First Page | Document Content | |
---|---|---|
![]() Orphan drugs Amines Food and Drug Administration Clinical research Pharmacology Omacetaxine mepesuccinate Pixantrone Chronic myelogenous leukemia Dasatinib Chemistry Medicine Organic chemistry | Source URL: www.fda.govDownload Document from Source WebsiteFile Size: 114,67 KBShare Document on Facebook |
![]() | FDA Review NDA[removed]Omapro™ (omacetaxine mepesuccinate) ODAC March 22, 2010 Amy McKee, M.D.DocID: GfBD - View Document |
![]() | Microsoft Word - ODAC briefing book 07JAN2010 FINALDocID: GcWw - View Document |
![]() | Microsoft PowerPoint - 1 Core Introduction (CI) FINALDocID: G22y - View Document |
![]() | ChemGenex Pharmaceuticals OMAPRO™ (omacetaxine mepesuccinate) ODAC Briefing Book ErrataDocID: FzZu - View Document |
![]() | Microsoft Word - ODAC briefing book Errata #2 page 51DocID: FnHN - View Document |